Shanghai Medicilon Inc. (SHA:688202)

Shanghai Medicilon Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	383.04	260.53	471.87	197.13	412.37	465.95
Short-Term Investments	21.12	178.76	-	-	-	-
Trading Asset Securities	170.09	261.22	518.23	-	100	-
Cash & Short-Term Investments	574.25	700.52	990.1	197.13	512.37	465.95
Cash Growth	-12.31%	-29.25%	402.25%	-61.52%	9.96%	-26.77%
Accounts Receivable	563.69	598.26	671.88	575.77	250.3	172.6
Other Receivables	18.72	18.04	3.05	3.06	1.61	3.28
Receivables	582.41	616.31	674.93	578.83	251.91	175.88
Inventory	102.02	104.36	165.52	171.12	83.48	32.69
Other Current Assets	63.99	14.51	45.64	125.54	44.28	24.77
Total Current Assets	1,323	1,436	1,876	1,073	892.04	699.29
Property, Plant & Equipment	753.81	810.18	849.97	763.66	554.59	353.94
Long-Term Investments	280.44	151.14	100.39	10.14	-	-
Other Intangible Assets	271.58	278.15	286.9	294.05	231.61	235.02
Long-Term Deferred Tax Assets	62.61	49.95	4.77	16.96	10.8	10.04
Long-Term Deferred Charges	94.96	97.49	144.07	148.45	65.44	57.39
Other Long-Term Assets	5.9	0.65	3.55	23.69	39.09	8.65
Total Assets	2,792	2,823	3,266	2,330	1,794	1,364
Accounts Payable	161.47	144.5	190.24	218.3	120.1	87.08
Accrued Expenses	39.58	49.59	49.63	50.02	53.09	41.01
Short-Term Debt	215.95	292.24	349.39	229.41	-	-
Current Portion of Long-Term Debt	40.83	0.02	-	-	-	-
Current Portion of Leases	-	12.15	19.21	19.78	13.3	-
Current Income Taxes Payable	8.03	-	-	-	10.15	3.99
Current Unearned Revenue	63.51	64.99	62.6	85.51	152.3	53.9
Other Current Liabilities	27.77	12.65	15.29	14.02	34.72	10.16
Total Current Liabilities	557.15	576.15	686.36	617.04	383.66	196.14
Long-Term Debt	97	21	-	-	-	-
Long-Term Leases	12.54	20.67	14.28	25.71	30.26	-
Long-Term Unearned Revenue	53.07	57.44	49.34	40.18	29.98	23.28
Long-Term Deferred Tax Liabilities	-	0.14	5.09	43.87	22.16	9.25
Other Long-Term Liabilities	8.82	7.71	-	-	-	-
Total Liabilities	728.57	683.1	755.07	726.8	466.06	228.67
Common Stock	134.35	134.67	134.67	87.02	62.08	62
Additional Paid-In Capital	1,656	1,662	1,662	714.74	717.57	756.61
Retained Earnings	373.36	403.05	733.9	801.04	547.86	304.7
Treasury Stock	-100.07	-59.99	-19.99	-	-	-
Comprehensive Income & Other	0.04	0.31	0.09	-0.01	-	-
Total Common Equity	2,063	2,140	2,511	1,603	1,328	1,123
Minority Interest	-	-	-	-	-	12.34
Shareholders' Equity	2,063	2,140	2,511	1,603	1,328	1,136
Total Liabilities & Equity	2,792	2,823	3,266	2,330	1,794	1,364
Total Debt	366.32	346.08	382.88	274.9	43.56	-
Net Cash (Debt)	207.93	354.44	607.22	-77.76	468.8	465.95
Net Cash Growth	-43.60%	-41.63%	-	-	0.61%	-26.77%
Net Cash Per Share	1.54	2.65	4.75	-0.64	3.86	3.84
Filing Date Shares Outstanding	146.83	133.67	134.67	121.82	121.68	121.52
Total Common Shares Outstanding	146.83	133.67	134.67	121.82	121.68	121.52
Working Capital	765.51	859.55	1,190	455.59	508.37	503.15
Book Value Per Share	14.05	16.01	18.64	13.16	10.91	9.24
Tangible Book Value	1,792	1,862	2,224	1,309	1,096	888.29
Tangible Book Value Per Share	12.20	13.93	16.51	10.74	9.01	7.31
Buildings	-	178.31	178.31	178.31	179.66	177.39
Machinery	-	810.44	797.29	626.44	410	313.12
Construction In Progress	-	169.19	142.71	140.39	100.62	10.83

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.